NCT07333469 2026-01-13
A Clinical Study of HX111 in Patients With Advanced Solid Tumor and Lymphoma
Hanx Biopharmaceuticals (Wuhan) Co., Ltd.
Phase 1/2 Not yet recruiting
Hanx Biopharmaceuticals (Wuhan) Co., Ltd.
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Celgene
Telik